Evidence map›Paper›PMID 32382513›Full record

ArticleJournal of clinical & translational endocrinology2020

Insulin secretory defect may be the major determinant of GDM in lean mothers.

M Fakhrul-Alam, Sharmin-Jahan, Mashfiqul-Hasan, Nusrat-Sultana, Mohona-Zaman, M Rakibul-Hasan, M Farid-Uddin, M A Hasanat

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical & translational endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Metabolomic Profiles of Nonobese and Obese Women With Gestational Diabetes.The Journal of clinical endocrinology and metabolism · 2023
    Article
  15. Article
  16. Article
  17. Metabolic Characteristics of Gestational Diabetes Mellitus and the Effects on Pregnancy Outcomes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

M Fakhrul-AlamDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
Sharmin-JahanDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
Mashfiqul-HasanDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
Nusrat-SultanaDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
Mohona-ZamanDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
M Rakibul-HasanDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
M Farid-UddinDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
M A HasanatDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Bangladesh.
Bangladesh Medical University · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo compare the insulin sensitivity and secretion indices of pregnant Bangladeshi women with GDM and normal glucose tolerance (NGT).

methodsThis cross sectional study was performed with 40 GDM and equal number of NGT pregnant women diagnosed on basis of WHO criterion-2013 during 24-40 weeks of gestation. Glucose was measured by glucose oxidase method and fasting insulin by chemiluminescent immunoassay. Equations of homeostatic model assessment (HOMA) were used to calculate indices of insulin resistance (HOMA-IR), β-cell function (HOMA-B) and insulin sensitivity (HOMA-%S).

resultsThe GDM group had significantly higher insulin resistance as indicated by higher fasting insulin value [GDM vs. NGT; 10.23 (7.94-14.50) vs. 7.07 (5.28-11.07) µIU/ml] and HOMA-IR [GDM vs. NGT; 2.47 (1.75-3.43) vs. 1.50 (0.99-2.22)] and poor β-cell secretion [GDM vs. NGT; HOMA-B: 113.37 (90.30-191.35) vs. 150.98 (109.85-271.72), median (IQR); p < 0.001 for all]. HOMA-B was significantly lower in GDM than NGT with BMI < 23 kg/m

conclusionsThough impairments of both insulin secretion and sensitivity are hallmarks in the pathogenesis of GDM, β-cell dysfunction contributes more to development of GDM in those with relatively lower BMI in our population.

Indexed as

GDMHOMAHOMA-BHOMA-IRInsulin resistanceInsulin secretion

Identifiers

PMID32382513
PMCPMC7199011
OpenAlexW3016587469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.